GEldridge

TL3 Regular · Málaga, ES

Clinician. Posts general information only, and says so every time.

Joined 15 September 2024 · last posted 3d · groups: clinicians

134 posts, newest first. Showing up to 150.

Prescription portability between countries Replied, post #112 · Access › International · 25 Jul 2026 · 0 likes post #111 answers the question as asked. The question underneath it is different. Language barriers: if you need to communicate with a supplier, clinician, or regulator…
How to ask a question when you cannot say why you are asking it Replied, post #51 · Start Here › How to Ask · 25 Jul 2026 · 0 likes On post #47 — agreed on the reasoning, with one qualification. Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply.…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #66 · Access › Insurance & coverage · 25 Jul 2026 · 15 likes Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and…
What steady state means for the decision to escalate Replied, post #32 · Practice › Dosing & titration · 20 Jul 2026 · 27 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Why the Start Here categories exist, and what they are not for Replied, post #12 · Start Here › Welcome · 19 Jul 2026 · 0 likes This follows post #9 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #72 · Practice › Administration · 17 Jul 2026 · 5 likes Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the stinging sensation substantially. This is the simplest thing to try…
Substitution between formats during a shortage — what changed since Replied, post #18 · Access › Shortages · 17 Jul 2026 · 15 likes On post #14 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #72 · Practice › Dosing & titration · 17 Jul 2026 · 24 likes Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that…
CJC-1295 with and without DAC: what the modification does Replied, post #111 · Compounds › Secretagogues & GH axis · 14 Jul 2026 · 0 likes Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single post-dose growth hormone level is nearly uninterpretable. Assessing…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #43 · Practice › Dosing & titration · 6 Jul 2026 · 8 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
Journal club: what we got wrong in an earlier session Replied, post #55 · Evidence › Journal club · 5 Jul 2026 · 12 likes On post #51 — agreed on the reasoning, with one qualification. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy.…
Reading order for a first week here, and what to skip until later — what changed since Replied, post #11 · Start Here › Welcome · 4 Jul 2026 · 10 likes Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #68 · Wellbeing › Sleep · 25 Jun 2026 · 0 likes Coming back to post #66, because the follow-up matters more than the original answer. Stimulants and sleep: if supplementing with caffeine or other stimulants for…
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #10 · Analytics › Home & field testing · 22 Jun 2026 · 0 likes Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result for the degraded sample, not for fresh material. That is…
Lipid changes during rapid weight loss: the expected trajectory Replied, post #6 · Clinical › Bloodwork · 20 Jun 2026 · 0 likes Worth separating two things that post #2 runs together. Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #12 · Analytics › Home & field testing · 19 Jun 2026 · 29 likes On post #8 — agreed on the reasoning, with one qualification. Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is…
Journal club: what we got wrong in an earlier session Replied, post #11 · Evidence › Journal club · 18 Jun 2026 · 19 likes On post #7 — agreed on the reasoning, with one qualification. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most…
Compounds this community declines to help with, and why — does this still hold? Replied, post #2 · Compounds › Other compounds · 14 Jun 2026 · 28 likes Worth separating two things that the opening post runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #22 · Documentation › Doc review · 13 Jun 2026 · 19 likes Interdependencies: if updating one page requires updating related pages, posting that connection here helps the maintainers see the scope of work.
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #71 · Safety › Contraindications · 12 Jun 2026 · 6 likes Diabetic retinopathy complications: a signal for this was noted in SUSTAIN 6. Current evidence is mixed. The risk is not zero and some caution is appropriate in people…
Reading a home test result without over-claiming Replied, post #70 · Analytics › Home & field testing · 7 Jun 2026 · 29 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #43 · Practice › Administration · 20 May 2026 · 0 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #104 · Research Methods › Statistics · 14 May 2026 · 19 likes Confounding: a third variable explains an apparent association. In randomised data, randomisation balances confounders. In observational data, confounders can be…
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #75 · Outcomes › Body composition · 13 May 2026 · 1 like I read post #73 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
The most useful thing you learned here that was not the answer you came for Replied, post #41 · Lounge › Off topic · 10 May 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Prescription requirements and telehealth models — a second dataset Replied, post #17 · Sourcing › Regulatory · 2 May 2026 · 28 likes Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal…
Amylin receptor signalling and satiety — what changed since Replied, post #71 · Pharmacology › Receptor biology · 30 Apr 2026 · 6 likes Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a receptor distinct from GLP-1. The hypothesis behind combination therapy is two…
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #125 · Analytics › Mass spectrometry · 29 Apr 2026 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
What a certificate commits its issuer to — one year on Replied, post #58 · Analytics › COA interpretation · 29 Apr 2026 · 28 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
The best-written scientific paper you have read Replied, post #20 · Lounge › Off topic · 27 Apr 2026 · 2 likes On post #16 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #118 · Analytics › Mass spectrometry · 27 Apr 2026 · 2 likes Coming back to post #116, because the follow-up matters more than the original answer. Resolution: "high resolution" commonly means
Converting between mg/mL and units per dose, both directions — the long version Replied, post #96 · Practice › Reconstitution · 24 Apr 2026 · 0 likes Worth separating two things that post #92 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
[2026 update] Waist circumference technique and its repeatability Replied, post #5 · Outcomes › Progress reports · 22 Apr 2026 · 14 likes post #4 answers the question as asked. The question underneath it is different. Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #39 · Sourcing › Independent verification · 15 Apr 2026 · 0 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose Replied, post #9 · Practice › Administration · 14 Apr 2026 · 20 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
Foaming during reconstitution and whether it matters — the long version Replied, post #96 · Practice › Reconstitution · 12 Apr 2026 · 29 likes I read post #94 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Started this topic · Evidence › Journal club · 7 Apr 2026 · 3 likes Asking directly, because I could not find a straight answer: Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Comparing STEP 2 ( Lancet ,…
[2026 update] Thyroid function tests during substantial weight change Replied, post #20 · Clinical › Bloodwork · 22 Mar 2026 · 0 likes On post #16 — agreed on the reasoning, with one qualification. Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #82 · Lounge › Introductions · 16 Mar 2026 · 7 likes On post #78 — agreed on the reasoning, with one qualification. Welcome: the response to introductions is usually welcome. People will reply to introduce themselves back…
Five questions in one post gets you one answer — how to split them Replied, post #27 · Start Here › How to Ask · 8 Mar 2026 · 17 likes This follows post #24 rather than contradicting it. Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick…
Absence of evidence and evidence of absence Replied, post #20 · Research Methods › Statistics · 4 Mar 2026 · 16 likes Multiplicity and multiple comparisons: if you test many hypotheses, the chance of finding a false positive by random chance increases. That is why pre-specifying the…
Foaming during reconstitution and whether it matters — the long version Replied, post #52 · Practice › Reconstitution · 4 Mar 2026 · 16 likes I read post #50 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
Why a compound being unapproved is not the same as being illegal to possess Replied, post #63 · Sourcing › Regulatory · 27 Feb 2026 · 23 likes Coming back to post #61, because the follow-up matters more than the original answer. Why this category is maintained as documentation, not as recommendations: the goal…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #53 · Pharmacology › Pharmacokinetics · 25 Feb 2026 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #3 · Practice › Interactions · 24 Feb 2026 · 14 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #5 · Compounds › Cagrilintide & amylin analogues · 13 Feb 2026 · 33 likes Worth separating two things that the opening post runs together. Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a…
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #73 · Documentation › Wiki requests · 5 Feb 2026 · 6 likes Authority and authorship: if you think a maintained page needs input from someone with specific expertise (a clinician, an analytical chemist) suggest who might…
Trifluoroacetate content and its consequences Replied, post #68 · Analytics › Impurities & related substances · 2 Feb 2026 · 0 likes Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
Trifluoroacetate content and its consequences Replied, post #15 · Analytics › Impurities & related substances · 24 Jan 2026 · 32 likes Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species…
Anaesthesia and elective surgery: the aspiration question Replied, post #2 · Practice › Interactions · 18 Jan 2026 · 27 likes On the opening post — agreed on the reasoning, with one qualification. Separation timing versus clinically important interaction: a separation timing inconvenience…
Coming back to: Training through a dose escalation week Replied, post #6 · Nutrition & Training › Resistance training · 10 Jan 2026 · 23 likes Coming back to post #4, because the follow-up matters more than the original answer. Programming while losing weight quickly: realistic expectations are crucial.…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #85 · Compounds › Semaglutide · 4 Jan 2026 · 24 likes The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #115 · Documentation › Doc review · 19 Dec 2025 · 32 likes Promoted topic withdrawal: if a promoted topic becomes outdated or inaccurate and the maintainer does not update, requesting withdrawal is appropriate.
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #15 · Pharmacology › Receptor biology · 16 Dec 2025 · 5 likes I read post #13 twice before replying, because I had assumed the opposite. GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion),…
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #8 · Sourcing › Logistics · 15 Dec 2025 · 15 likes I read post #6 twice before replying, because I had assumed the opposite. Tracking stops updating: tracking last updated days ago usually means the package is in…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #36 · Access › Pricing · 13 Dec 2025 · 21 likes Discount programmes and coupons: manufacturers often offer coupons that reduce out-of-pocket costs if insurance is not covering or is covering at a high copay. These…
Publication bias detection and its low power — does this still hold? Replied, post #2 · Evidence › Meta-analyses · 10 Dec 2025 · 0 likes Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline risk is specified. More interpretable than pooled relative effects.
Publishing an inconvenient result: a case study — the long version Replied, post #65 · Sourcing › Independent verification · 10 Dec 2025 · 12 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Batch date after test date, and other internal inconsistencies Replied, post #24 · Analytics › COA interpretation · 6 Dec 2025 · 2 likes post #23 is right about the mechanism and I think understates the practical bit. Water content (residual moisture) matters: lyophilised peptide is not dry. A few…
Pooling trials with different estimands — what changed since Replied, post #60 · Evidence › Meta-analyses · 3 Dec 2025 · 0 likes Publication bias: what did not get published? Small studies with negative results are less likely to be published than large studies with positive results. A forest…
Where the integrator drew the baseline, and how much it moved the number Replied, post #22 · Analytics › HPLC & UHPLC · 24 Nov 2025 · 0 likes Picking up post #19: that is the part I would want checked first. Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher…
Coming back to: Pen dose counters: what a click does and does not guarantee Started this topic · Devices › Pens & autoinjectors · 21 Nov 2025 · 0 likes Pen dose counters: what a click does and does not guarantee — setting out what I have, and where I think it stops being reliable. A question about technique rather than…
Pen dose counters: what a click does and does not guarantee Replied, post #14 · Devices › Pens & autoinjectors · 13 Nov 2025 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
[2026 update] What steady state means for the decision to escalate Replied, post #37 · Practice › Dosing & titration · 8 Nov 2025 · 13 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
Titles that describe the question, not the situation Replied, post #134 · Start Here › How to Ask · 29 Oct 2025 · 5 likes post #133 is right about the mechanism and I think understates the practical bit. Lab result questions: state the result, the reference interval, and what else is on…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #108 · Compounds › Tirzepatide · 24 Oct 2025 · 30 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #148 · Practice › Reconstitution · 19 Oct 2025 · 0 likes Worth separating two things that post #144 runs together. How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is…
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #40 · Start Here › Welcome · 16 Oct 2025 · 0 likes The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #72 · Documentation › Doc review · 10 Oct 2025 · 0 likes Review date disputes: if a maintained page's review date is approaching and it has not been updated, post a note so the maintainers notice.
The nausea timeline across the first four weeks, with a tabulated log Replied, post #132 · Practice › Side effects · 8 Oct 2025 · 14 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #42 · Compounds › Oral incretins · 25 Sep 2025 · 5 likes PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was demonstrated. The point estimates favoured the…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #8 · Evidence › Study critique · 12 Sep 2025 · 0 likes When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The critique might still be real but smaller than you…
Why the timeline is on the right and not the left Replied, post #63 · Meta › Site feedback · 3 Sep 2025 · 31 likes Community norms: if you think a norm has drifted or is not being followed consistently, raising it here can prompt discussion and realignment.
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #35 · Practice › Dosing & titration · 2 Sep 2025 · 18 likes I read post #33 twice before replying, because I had assumed the opposite. Reaching a dose and staying there for a year: the question of whether a stable dose remains…
A parcel that arrived warm: a decision process, not a verdict Replied, post #21 · Practice › Storage & stability · 1 Sep 2025 · 0 likes On post #17 — agreed on the reasoning, with one qualification. Published stability data applies specifically to the formulation studied, under the specific conditions…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #99 · Data & Tools › Calculators · 30 Aug 2025 · 1 like Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are fixed when identified.
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #110 · Evidence › Journal club · 25 Aug 2025 · 3 likes post #109 is right about the mechanism and I think understates the practical bit. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not…
Cross-border purchase rules within the EU Replied, post #4 · Regional › European Union · 24 Aug 2025 · 5 likes Germany: BfArM implements EU framework. Statutory insurance (the majority) excludes "lifestyle medicines" including weight management. Private prescription is common.…
Enforcement priorities versus written rules — does this still hold? Replied, post #19 · Sourcing › Regulatory · 20 Aug 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Are there stupid questions here? A staff answer, at length Replied, post #66 · Start Here › Welcome · 12 Aug 2025 · 14 likes post #65 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #96 · Compounds › Repair & healing peptides · 9 Aug 2025 · 19 likes On post #92 — agreed on the reasoning, with one qualification. BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and…
A request that was declined, and the reasoning — a second dataset Replied, post #28 · Documentation › Wiki requests · 8 Aug 2025 · 0 likes Picking up post #25: that is the part I would want checked first. Correction requests: if you spot an error in a maintained page, note it here with the specific…
A ten-fold dose error caught before injection — one year on Replied, post #60 · Devices › Syringes & needles · 2 Aug 2025 · 0 likes Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the plunger to check for blood) is not necessary and is sometimes discouraged…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #152 · Compounds › Tirzepatide · 1 Aug 2025 · 0 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
Sequence verification for an obscure compound: how it is done Replied, post #108 · Compounds › Other compounds · 29 Jul 2025 · 3 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
Coming back to: Official shortage notices and what they authorise Replied, post #62 · Access › Shortages · 19 Jul 2025 · 0 likes post #61 answers the question as asked. The question underneath it is different. Patient advocacy during shortages: some advocacy groups advocate for patients during…
Reflectance and photometric devices: precision in practice Replied, post #2 · marked as the solution · Analytics › Home & field testing · 12 Jul 2025 · 7 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Publishing an inconvenient result: a case study Replied, post #48 · Sourcing › Independent verification · 12 Jul 2025 · 0 likes Worth separating two things that post #44 runs together. When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review,…
Counter-ion content and its effect on measured mass Replied, post #85 · Analytics › Mass spectrometry · 7 Jul 2025 · 3 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
Discussing something you have already been doing — the long version Replied, post #5 · Clinical › Prescriber conversations · 6 Jul 2025 · 31 likes How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence for this shows X benefit in people with my condition; would it be…
Sodium, potassium and magnesium when intake drops Replied, post #44 · Nutrition & Training › Hydration & electrolytes · 5 Jul 2025 · 0 likes Worth separating two things that post #40 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
Which panel is worth repeating and which is worth ignoring Replied, post #53 · Clinical › Bloodwork · 5 Jul 2025 · 5 likes Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
[2026 update] Clearance pathways and what renal impairment changes Replied, post #66 · Pharmacology › Pharmacokinetics · 26 Jun 2025 · 7 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #57 · Clinical › Comorbidities · 22 Jun 2025 · 0 likes On post #53 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
Coming back to: When "no data" is the complete and final answer Replied, post #15 · Compounds › Other compounds · 16 Jun 2025 · 0 likes post #14 answers the question as asked. The question underneath it is different. Sequence verification: for an obscure compound, a report of the amino acid sequence or…
A report I filed that turned out to be wrong, and the correction Replied, post #84 · Sourcing › Vendor reports · 3 Jun 2025 · 30 likes post #83 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #74 · Practice › Reconstitution · 20 May 2025 · 26 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
Reading a trial's population section before its results — does this still hold? Replied, post #116 · Evidence › Trials · 18 May 2025 · 18 likes Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in. HbA1c is a surrogate for long-term glucose control and the…
Pregnancy as an absolute contraindication Replied, post #24 · Safety › Contraindications · 17 May 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Coverage for the indication versus for the drug Replied, post #46 · Access › Insurance & coverage · 29 Apr 2025 · 25 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
Shakes versus food: a pragmatic assessment — the long version Replied, post #5 · Nutrition & Training › Protein & intake · 20 Apr 2025 · 0 likes Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per kilogram of body weight. Individual requirements vary but that range is a…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #83 · Practice › Reconstitution · 19 Apr 2025 · 0 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
Retatrutide dose escalation in the published trials Replied, post #62 · Compounds › Retatrutide · 29 Mar 2025 · 7 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
Coming back to: What published stability data actually covers, and what it does not Replied, post #12 · Practice › Storage & stability · 28 Mar 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Preparing for an appointment: one page, three questions Replied, post #12 · Clinical › Prescriber conversations · 24 Mar 2025 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
An orphaned page with no inbound links Replied, post #20 · Meta › Wiki maintenance · 22 Mar 2025 · 3 likes I read post #18 twice before replying, because I had assumed the opposite. Authority: if you think a page needs input from someone with specific expertise, suggesting…
Triple agonism: additive, synergistic, or neither? Replied, post #28 · Compounds › Retatrutide · 19 Mar 2025 · 5 likes Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
Coverage for the indication versus for the drug Replied, post #5 · Access › Insurance & coverage · 19 Mar 2025 · 17 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #134 · Sourcing › Vendor reports · 19 Mar 2025 · 9 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #50 · Evidence › Journal club · 17 Mar 2025 · 0 likes On post #46 — agreed on the reasoning, with one qualification. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has…
A ten-fold dose error caught before injection Replied, post #8 · Devices › Syringes & needles · 11 Mar 2025 · 0 likes post #7 answers the question as asked. The question underneath it is different. Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are…
Review: a draft on reconstitution arithmetic, with objections Replied, post #49 · Documentation › Doc review · 8 Mar 2025 · 6 likes New maintainer recruitment: if a page's maintainer is inactive and updates are needed, suggesting a new maintainer here can help transition responsibility.
Pharmaceutical compounding rules, summarised from primary sources Replied, post #92 · Sourcing › Regulatory · 3 Mar 2025 · 2 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #71 · Sourcing › Regulatory · 2 Mar 2025 · 26 likes post #70 is right about the mechanism and I think understates the practical bit. Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #118 · Evidence › Journal club · 6 Feb 2025 · 3 likes post #117 answers the question as asked. The question underneath it is different. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0…
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #12 · Evidence › Meta-analyses · 27 Jan 2025 · 27 likes post #11 answers the question as asked. The question underneath it is different. Pooled estimates and heterogeneity: when trials differ in population, duration, or…
Why mass spectrometry cannot tell you about an epimer Replied, post #28 · Analytics › Mass spectrometry · 15 Jan 2025 · 0 likes Picking up post #25: that is the part I would want checked first. Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical…
What we do not know about retatrutide, listed explicitly Replied, post #51 · Compounds › Retatrutide · 10 Jan 2025 · 29 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
When "no data" is the complete and final answer Replied, post #59 · Compounds › Other compounds · 6 Jan 2025 · 27 likes Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not arbitrary. They exist because of failure modes that have…
[2026 update] New subcategory: rationale and scope Replied, post #115 · Meta › Announcements · 2 Jan 2025 · 7 likes Worth separating two things that post #111 runs together. Feedback to announcements: if you have feedback on an announced change (not a question, but your position)…
[2026 update] New subcategory: rationale and scope Replied, post #65 · Meta › Announcements · 14 Dec 2024 · 12 likes Coming back to post #63, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #39 · Practice › Reconstitution · 7 Dec 2024 · 10 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #57 · Compounds › Semaglutide · 3 Dec 2024 · 18 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
EMA product information as a primary source — does this still hold? Replied, post #138 · Regional › European Union · 18 Nov 2024 · 1 like Italy: AIFA controls reimbursement through a note system. Weight-management indications have not attracted public reimbursement. Regional health authorities add further…
How to ask for a dose change without antagonising anyone — what changed since Replied, post #73 · Clinical › Prescriber conversations · 18 Nov 2024 · 2 likes I read post #71 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
Requesting a page: what makes a good request — what changed since Replied, post #106 · Documentation › Wiki requests · 12 Oct 2024 · 33 likes Authority and authorship: if you think a maintained page needs input from someone with specific expertise (a clinician, an analytical chemist) suggest who might…
Second pass at: Hoarding and why it makes a shortage worse Replied, post #88 · Access › Shortages · 12 Oct 2024 · 19 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
Blind submission and why it changes minds Replied, post #84 · Sourcing › Independent verification · 10 Oct 2024 · 17 likes Picking up post #81: that is the part I would want checked first. Service differences on vendor pages: Janoshik and Medutest results are measurements on vials.…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #84 · Sourcing › Independent verification · 25 Sep 2024 · 22 likes Coming back to post #82, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #7 · Compounds › Other compounds · 18 Sep 2024 · 7 likes This follows post #4 rather than contradicting it. How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another.…
Why a preprint's supplementary material is often the best part Replied, post #12 · Evidence › Preprints · 4 Sep 2024 · 7 likes Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed is useful but comes at the cost of not yet having…
Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #31 · Compounds › Oral incretins · 1 Sep 2024 · 1 like Coming back to post #29, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
The topic list is dense — is that deliberate? Replied, post #15 · Meta › Site feedback · 17 Aug 2024 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Guidelines revision: what changed and why Replied, post #16 · Meta › Announcements · 25 Jul 2024 · 18 likes Questions welcomed: if an announcement is unclear, asking for clarification is welcome. Staff will explain their reasoning.